436 related articles for article (PubMed ID: 37654796)
1. The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update.
Çetinarslan T; Kümper L; Fölster-Holst R
Front Mol Biosci; 2023; 10():1159404. PubMed ID: 37654796
[TBL] [Abstract][Full Text] [Related]
2. Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review.
Demessant-Flavigny AL; Connétable S; Kerob D; Moreau M; Aguilar L; Wollenberg A
J Eur Acad Dermatol Venereol; 2023 Jun; 37 Suppl 5():3-17. PubMed ID: 37232427
[TBL] [Abstract][Full Text] [Related]
3. Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin.
Levin J; Friedlander SF; Del Rosso JQ
J Clin Aesthet Dermatol; 2013 Oct; 6(10):16-22. PubMed ID: 24155988
[TBL] [Abstract][Full Text] [Related]
4. Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives.
Stefanovic N; Irvine AD
Ann Allergy Asthma Immunol; 2024 Feb; 132(2):187-195. PubMed ID: 37758055
[TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin.
Levin J; Friedlander SF; Del Rosso JQ
J Clin Aesthet Dermatol; 2013 Nov; 6(11):49-54. PubMed ID: 24307926
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review.
Upadhyay PR; Seminario-Vidal L; Abe B; Ghobadi C; Sims JT
Cells; 2023 Dec; 12(24):. PubMed ID: 38132113
[TBL] [Abstract][Full Text] [Related]
7. Microbiome in atopic dermatitis.
Wollina U
Clin Cosmet Investig Dermatol; 2017; 10():51-56. PubMed ID: 28260936
[TBL] [Abstract][Full Text] [Related]
8. Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort.
Gonzalez T; Stevens ML; Baatyrbek Kyzy A; Alarcon R; He H; Kroner JW; Spagna D; Grashel B; Sidler E; Martin LJ; Biagini Myers JM; Khurana Hershey GK; Herr AB
Allergy; 2021 Jan; 76(1):302-313. PubMed ID: 32640045
[TBL] [Abstract][Full Text] [Related]
9. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
Beck LA; Cork MJ; Amagai M; De Benedetto A; Kabashima K; Hamilton JD; Rossi AB
JID Innov; 2022 Sep; 2(5):100131. PubMed ID: 36059592
[TBL] [Abstract][Full Text] [Related]
10. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
[TBL] [Abstract][Full Text] [Related]
11. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
Oh JS; Seong GS; Kim YD; Choung SY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis.
Cau L; Williams MR; Butcher AM; Nakatsuji T; Kavanaugh JS; Cheng JY; Shafiq F; Higbee K; Hata TR; Horswill AR; Gallo RL
J Allergy Clin Immunol; 2021 Mar; 147(3):955-966.e16. PubMed ID: 32634452
[TBL] [Abstract][Full Text] [Related]
13. Significance of Skin Barrier Dysfunction in Atopic Dermatitis.
Kim BE; Leung DYM
Allergy Asthma Immunol Res; 2018 May; 10(3):207-215. PubMed ID: 29676067
[TBL] [Abstract][Full Text] [Related]
14. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction.
Kim J; Kim BE; Berdyshev E; Bronova I; Bin L; Bae J; Kim S; Kim HY; Lee UH; Kim MS; Kim H; Lee J; Hall CF; Hui-Beckman J; Chang Y; Bronoff AS; Hwang D; Lee HY; Goleva E; Ahn K; Leung DYM
Allergy; 2023 May; 78(5):1292-1306. PubMed ID: 36609802
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect and metabolic mechanism of BS012, a mixture of Asarum sieboldii, Platycodon grandiflorum, and Cinnamomum cassia extracts, on atopic dermatitis in vivo and in vitro.
Lee G; Park J; Lee H; Kim KS; Park JH; Kyung SY; Kim HS; Yang HO; Jung BH
Phytomedicine; 2023 Jul; 115():154818. PubMed ID: 37187105
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and Implications of Bacterial Invasion across the Human Skin Barrier.
Lipsky ZW; Patsy M; Marques CNH; German GK
Microbiol Spectr; 2022 Jun; 10(3):e0274421. PubMed ID: 35532353
[TBL] [Abstract][Full Text] [Related]
18. Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis.
Orfali RL; Aoki V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839897
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between Atopic Dermatitis and
Kim J; Kim BE; Ahn K; Leung DYM
Allergy Asthma Immunol Res; 2019 Sep; 11(5):593-603. PubMed ID: 31332972
[No Abstract] [Full Text] [Related]
20. Counterregulation between thymic stromal lymphopoietin- and IL-23-driven immune axes shapes skin inflammation in mice with epidermal barrier defects.
Li J; Leyva-Castillo JM; Hener P; Eisenmann A; Zaafouri S; Jonca N; Serre G; Birling MC; Li M
J Allergy Clin Immunol; 2016 Jul; 138(1):150-161.e13. PubMed ID: 26993035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
